Becton Dickinson (BDX) Tops Q3 EPS by 16c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
BD REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS
August 4, 2022 6:30 AM EDTRevenue from continuing operations of $4.6 billion increased 0.7% as reported and 3.8% on currency-neutral basisRevenue from continuing operations driven by base revenue growth of 6.0% as reported, 9.3% currency-neutralWorldwide COVID-only testing revenues of $76 million declined from $300 million in the prior yearGAAP diluted EPS from continuing operations of $1.28; adjusted diluted EPS from continuing operations of $2.66Company raises full year revenue and EPS guidance
FRANKLIN LAKES, N.J., Aug. 4, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its third quarter of fiscal year... More
